Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Comment by MDbioguyon May 08, 2009 4:27pm
374 Views
Post# 15979499

RE: we know our pps won't go lower then 15

RE: we know our pps won't go lower then 15

Roche is waiting for it to collapse.  I am sure they have a first right of refusal for the flu side of this technology if this happens.  The number of flu cases will go down until next flu season.  And, the total world wide means nothing.  Only cases where insurance companies reimburse mean anything to this company.  In addition, there are so many competitors and new technologies coming.  Aside from flu, sales of West Nile and Biodefense products go down every year.  Why they keep them going is beyond me.  I am not sure the cardiac will ever be accepted as a test to be run on every patient.  

Bullboard Posts